Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine â A combined analysis of five phase III clinical trials

Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine â A combined analysis of five phase III clinical trials

Background: The immunogenicity profile of the 9-valent HPV (9vHPV) vaccine was evaluated across five phase III clinical studies conducted in girls and boys 9â15 years of age and young women 16â26 years of age. The effect of baseline characteristics of subjects on vaccine-induced HPV antibody respons...

Full description

Bibliographic Details
Main Authors: Lone K. Petersen, Jaime Restrepo, Edson D. Moreira Jr., Ole-Erik Iversen, Punnee Pitisuttithum, Pierre Van Damme, Elmar A. Joura, Sven-Erik Olsson, Daron Ferris, Stan Block, Anna R. Giuliano, Xavier Bosch, Sophie Pils, Jack Cuzick, Suzanne M. Garland, Warner Huh, Susanne K. Kjaer, Oliver M. Bautista, Donna Hyatt, Roger Maansson, Erin Moeller, Hong Qi, Christine Roberts, Alain Luxembourg
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Papillomavirus Research
Online Access:http://www.sciencedirect.com/science/article/pii/S2405852116300660

Internet

http://www.sciencedirect.com/science/article/pii/S2405852116300660

Similar Items